nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—PPARA—liver cancer	0.675	1	CbGaD
Gemfibrozil—CYP2C8—Sorafenib—liver cancer	0.0351	0.252	CbGbCtD
Gemfibrozil—CYP2C19—Sorafenib—liver cancer	0.0294	0.212	CbGbCtD
Gemfibrozil—CYP1A2—Sorafenib—liver cancer	0.0272	0.195	CbGbCtD
Gemfibrozil—CYP2C9—Sorafenib—liver cancer	0.0245	0.176	CbGbCtD
Gemfibrozil—CYP3A4—Sorafenib—liver cancer	0.0142	0.102	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—liver cancer	0.00864	0.0621	CbGbCtD
Gemfibrozil—Urogenital disorder—Sorafenib—liver cancer	0.00744	0.0826	CcSEcCtD
Gemfibrozil—Hepatocellular carcinoma—Sorafenib—liver cancer	0.00669	0.0743	CcSEcCtD
Gemfibrozil—Hepatic cancer—Sorafenib—liver cancer	0.00609	0.0676	CcSEcCtD
Gemfibrozil—Cerebral haemorrhage—Sorafenib—liver cancer	0.00221	0.0245	CcSEcCtD
Gemfibrozil—Cholecystitis—Sorafenib—liver cancer	0.00213	0.0236	CcSEcCtD
Gemfibrozil—Rhabdomyolysis—Sorafenib—liver cancer	0.00138	0.0153	CcSEcCtD
Gemfibrozil—Drug interaction—Sorafenib—liver cancer	0.00132	0.0146	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Sorafenib—liver cancer	0.00129	0.0143	CcSEcCtD
Gemfibrozil—Eczema—Sorafenib—liver cancer	0.000987	0.011	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Sorafenib—liver cancer	0.00094	0.0104	CcSEcCtD
Gemfibrozil—Peripheral vascular disorder—Epirubicin—liver cancer	0.000921	0.0102	CcSEcCtD
Gemfibrozil—Peripheral vascular disorder—Doxorubicin—liver cancer	0.000852	0.00946	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Sorafenib—liver cancer	0.00081	0.00899	CcSEcCtD
Gemfibrozil—Breast disorder—Sorafenib—liver cancer	0.000801	0.0089	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Sorafenib—liver cancer	0.000793	0.0088	CcSEcCtD
Gemfibrozil—Pancreatitis—Sorafenib—liver cancer	0.000752	0.00834	CcSEcCtD
Gemfibrozil—Myasthenia—Epirubicin—liver cancer	0.000718	0.00797	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Sorafenib—liver cancer	0.000706	0.00784	CcSEcCtD
Gemfibrozil—Weight decreased—Sorafenib—liver cancer	0.000693	0.0077	CcSEcCtD
Gemfibrozil—Renal failure—Sorafenib—liver cancer	0.000672	0.00746	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Sorafenib—liver cancer	0.00067	0.00744	CcSEcCtD
Gemfibrozil—Bone marrow depression—Epirubicin—liver cancer	0.000669	0.00742	CcSEcCtD
Gemfibrozil—Jaundice—Sorafenib—liver cancer	0.000666	0.0074	CcSEcCtD
Gemfibrozil—Myasthenia—Doxorubicin—liver cancer	0.000665	0.00738	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Sorafenib—liver cancer	0.000646	0.00718	CcSEcCtD
Gemfibrozil—Bone marrow depression—Doxorubicin—liver cancer	0.000619	0.00687	CcSEcCtD
Gemfibrozil—Neuritis—Epirubicin—liver cancer	0.000605	0.00671	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Sorafenib—liver cancer	0.000603	0.00669	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Epirubicin—liver cancer	0.000575	0.00639	CcSEcCtD
Gemfibrozil—Neuritis—Doxorubicin—liver cancer	0.00056	0.00621	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Sorafenib—liver cancer	0.000553	0.00614	CcSEcCtD
Gemfibrozil—Alopecia—Sorafenib—liver cancer	0.000542	0.00602	CcSEcCtD
Gemfibrozil—Mental disorder—Sorafenib—liver cancer	0.000538	0.00597	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Doxorubicin—liver cancer	0.000532	0.00591	CcSEcCtD
Gemfibrozil—Dysgeusia—Sorafenib—liver cancer	0.000523	0.00581	CcSEcCtD
Gemfibrozil—Jaundice cholestatic—Epirubicin—liver cancer	0.000514	0.0057	CcSEcCtD
Gemfibrozil—Anaemia—Sorafenib—liver cancer	0.000494	0.00548	CcSEcCtD
Gemfibrozil—Angioedema—Sorafenib—liver cancer	0.000488	0.00542	CcSEcCtD
Gemfibrozil—Syncope—Sorafenib—liver cancer	0.000479	0.00532	CcSEcCtD
Gemfibrozil—Leukopenia—Sorafenib—liver cancer	0.000478	0.00531	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Epirubicin—liver cancer	0.000477	0.0053	CcSEcCtD
Gemfibrozil—Jaundice cholestatic—Doxorubicin—liver cancer	0.000475	0.00528	CcSEcCtD
Gemfibrozil—Loss of consciousness—Sorafenib—liver cancer	0.000469	0.00521	CcSEcCtD
Gemfibrozil—Cough—Sorafenib—liver cancer	0.000466	0.00517	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Epirubicin—liver cancer	0.000457	0.00507	CcSEcCtD
Gemfibrozil—Arthralgia—Sorafenib—liver cancer	0.000455	0.00505	CcSEcCtD
Gemfibrozil—Myalgia—Sorafenib—liver cancer	0.000455	0.00505	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000452	0.00501	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000452	0.00501	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Doxorubicin—liver cancer	0.000442	0.0049	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Sorafenib—liver cancer	0.000436	0.00484	CcSEcCtD
Gemfibrozil—Colitis—Epirubicin—liver cancer	0.000434	0.00481	CcSEcCtD
Gemfibrozil—Shock—Sorafenib—liver cancer	0.000429	0.00476	CcSEcCtD
Gemfibrozil—Nervous system disorder—Sorafenib—liver cancer	0.000427	0.00475	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Sorafenib—liver cancer	0.000427	0.00474	CcSEcCtD
Gemfibrozil—Skin disorder—Sorafenib—liver cancer	0.000423	0.0047	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Doxorubicin—liver cancer	0.000423	0.00469	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000418	0.00464	CcSEcCtD
Gemfibrozil—Colitis—Doxorubicin—liver cancer	0.000401	0.00445	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000397	0.00441	CcSEcCtD
Gemfibrozil—Dyspepsia—Sorafenib—liver cancer	0.000384	0.00426	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000377	0.00418	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Sorafenib—liver cancer	0.000376	0.00418	CcSEcCtD
Gemfibrozil—Fatigue—Sorafenib—liver cancer	0.000376	0.00417	CcSEcCtD
Gemfibrozil—Photosensitivity—Epirubicin—liver cancer	0.000373	0.00414	CcSEcCtD
Gemfibrozil—Constipation—Sorafenib—liver cancer	0.000373	0.00414	CcSEcCtD
Gemfibrozil—Pain—Sorafenib—liver cancer	0.000373	0.00414	CcSEcCtD
Gemfibrozil—Eczema—Epirubicin—liver cancer	0.000365	0.00405	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Sorafenib—liver cancer	0.000356	0.00396	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000349	0.00387	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Epirubicin—liver cancer	0.000347	0.00386	CcSEcCtD
Gemfibrozil—Urticaria—Sorafenib—liver cancer	0.000346	0.00384	CcSEcCtD
Gemfibrozil—Photosensitivity—Doxorubicin—liver cancer	0.000345	0.00383	CcSEcCtD
Gemfibrozil—Abdominal pain—Sorafenib—liver cancer	0.000345	0.00383	CcSEcCtD
Gemfibrozil—Eczema—Doxorubicin—liver cancer	0.000337	0.00375	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000321	0.00357	CcSEcCtD
Gemfibrozil—Asthenia—Sorafenib—liver cancer	0.000313	0.00347	CcSEcCtD
Gemfibrozil—Pruritus—Sorafenib—liver cancer	0.000308	0.00342	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—liver cancer	0.000303	0.00336	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—liver cancer	0.000299	0.00332	CcSEcCtD
Gemfibrozil—Diarrhoea—Sorafenib—liver cancer	0.000298	0.00331	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—liver cancer	0.000296	0.00329	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—liver cancer	0.000293	0.00325	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—liver cancer	0.000289	0.00321	CcSEcCtD
Gemfibrozil—Dizziness—Sorafenib—liver cancer	0.000288	0.0032	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—liver cancer	0.00028	0.00311	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—liver cancer	0.00028	0.00311	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—liver cancer	0.000278	0.00308	CcSEcCtD
Gemfibrozil—Vomiting—Sorafenib—liver cancer	0.000277	0.00308	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—liver cancer	0.000277	0.00307	CcSEcCtD
Gemfibrozil—Rash—Sorafenib—liver cancer	0.000275	0.00305	CcSEcCtD
Gemfibrozil—Dermatitis—Sorafenib—liver cancer	0.000275	0.00305	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—liver cancer	0.000274	0.00304	CcSEcCtD
Gemfibrozil—Headache—Sorafenib—liver cancer	0.000273	0.00303	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—liver cancer	0.000271	0.00301	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—liver cancer	0.000269	0.00299	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—liver cancer	0.000267	0.00297	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—liver cancer	0.00026	0.00288	CcSEcCtD
Gemfibrozil—Nausea—Sorafenib—liver cancer	0.000259	0.00287	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—liver cancer	0.000259	0.00287	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—liver cancer	0.000257	0.00285	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—liver cancer	0.000256	0.00285	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—liver cancer	0.000249	0.00276	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—liver cancer	0.000248	0.00276	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—liver cancer	0.000248	0.00275	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—liver cancer	0.000246	0.00273	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—liver cancer	0.000246	0.00273	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—liver cancer	0.000239	0.00266	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—liver cancer	0.000239	0.00265	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—liver cancer	0.000237	0.00263	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—liver cancer	0.00023	0.00255	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—liver cancer	0.000229	0.00254	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—liver cancer	0.000228	0.00253	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—liver cancer	0.000227	0.00252	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—liver cancer	0.000227	0.00252	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—liver cancer	0.000226	0.0025	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—liver cancer	0.000223	0.00247	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—liver cancer	0.000221	0.00245	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—liver cancer	0.000212	0.00235	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—liver cancer	0.00021	0.00233	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—liver cancer	0.000209	0.00232	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—liver cancer	0.000206	0.00229	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—liver cancer	0.000204	0.00227	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—liver cancer	0.0002	0.00222	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—liver cancer	0.000199	0.00221	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—liver cancer	0.000196	0.00218	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—liver cancer	0.000194	0.00216	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—liver cancer	0.000194	0.00215	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—liver cancer	0.000193	0.00215	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—liver cancer	0.000192	0.00213	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—liver cancer	0.000189	0.0021	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—liver cancer	0.000186	0.00206	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—liver cancer	0.000185	0.00206	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—liver cancer	0.000184	0.00204	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—liver cancer	0.000182	0.00203	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—liver cancer	0.00018	0.002	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—liver cancer	0.000179	0.00199	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—liver cancer	0.000179	0.00199	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—liver cancer	0.000177	0.00197	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—liver cancer	0.000177	0.00197	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—liver cancer	0.000177	0.00196	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—liver cancer	0.000177	0.00196	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—liver cancer	0.000173	0.00193	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—liver cancer	0.000172	0.00191	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—liver cancer	0.000172	0.00191	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—liver cancer	0.000171	0.0019	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—liver cancer	0.000169	0.00187	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—liver cancer	0.000168	0.00187	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—liver cancer	0.000168	0.00187	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—liver cancer	0.000168	0.00187	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000167	0.00185	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—liver cancer	0.000164	0.00182	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—liver cancer	0.000164	0.00182	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—liver cancer	0.000163	0.00181	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—liver cancer	0.000162	0.0018	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—liver cancer	0.000161	0.00179	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—liver cancer	0.000161	0.00179	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—liver cancer	0.000161	0.00178	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—liver cancer	0.000159	0.00177	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—liver cancer	0.000158	0.00176	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—liver cancer	0.000158	0.00176	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—liver cancer	0.000158	0.00175	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—liver cancer	0.000158	0.00175	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—liver cancer	0.000156	0.00174	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—liver cancer	0.000155	0.00173	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—liver cancer	0.000155	0.00173	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—liver cancer	0.000155	0.00173	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000154	0.00171	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—liver cancer	0.00015	0.00167	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—liver cancer	0.000149	0.00165	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—liver cancer	0.000149	0.00165	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000147	0.00163	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—liver cancer	0.000147	0.00163	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—liver cancer	0.000146	0.00162	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—liver cancer	0.000146	0.00162	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—liver cancer	0.000145	0.00161	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—liver cancer	0.000145	0.00161	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—liver cancer	0.000143	0.00159	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—liver cancer	0.000142	0.00157	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—liver cancer	0.000139	0.00154	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—liver cancer	0.000139	0.00154	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—liver cancer	0.000138	0.00153	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—liver cancer	0.000138	0.00153	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000136	0.00151	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—liver cancer	0.000134	0.00149	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—liver cancer	0.000133	0.00147	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—liver cancer	0.000133	0.00147	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—liver cancer	0.000132	0.00146	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—liver cancer	0.000131	0.00146	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000129	0.00143	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—liver cancer	0.000129	0.00143	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—liver cancer	0.000128	0.00142	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—liver cancer	0.000127	0.00141	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—liver cancer	0.000127	0.00141	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—liver cancer	0.000127	0.00141	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—liver cancer	0.000123	0.00136	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—liver cancer	0.000122	0.00135	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—liver cancer	0.000118	0.00131	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—liver cancer	0.000118	0.00131	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—liver cancer	0.000116	0.00128	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—liver cancer	0.000114	0.00127	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—liver cancer	0.00011	0.00122	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—liver cancer	0.000107	0.00119	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—liver cancer	0.000107	0.00118	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—liver cancer	0.000105	0.00117	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—liver cancer	0.000102	0.00114	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—liver cancer	0.000102	0.00113	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—liver cancer	0.000102	0.00113	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—liver cancer	0.000101	0.00113	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—liver cancer	0.000101	0.00112	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—liver cancer	9.86e-05	0.00109	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—liver cancer	9.57e-05	0.00106	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—liver cancer	9.48e-05	0.00105	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—liver cancer	9.4e-05	0.00104	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—liver cancer	9.39e-05	0.00104	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—liver cancer	9.34e-05	0.00104	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—liver cancer	8.85e-05	0.000983	CcSEcCtD
Gemfibrozil—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.51e-05	0.000262	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.49e-05	0.000261	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—liver cancer	2.49e-05	0.00026	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.47e-05	0.000259	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—KRAS—liver cancer	2.47e-05	0.000258	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1A1—liver cancer	2.46e-05	0.000258	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.45e-05	0.000256	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.44e-05	0.000255	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—UGDH—liver cancer	2.43e-05	0.000254	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PPARG—liver cancer	2.4e-05	0.000251	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—HPGDS—liver cancer	2.37e-05	0.000248	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.36e-05	0.000247	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—MTHFR—liver cancer	2.3e-05	0.00024	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.29e-05	0.00024	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EPT1—liver cancer	2.28e-05	0.000239	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TAT—liver cancer	2.17e-05	0.000227	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—SERPINE1—liver cancer	2.16e-05	0.000226	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.15e-05	0.000225	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.13e-05	0.000223	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.12e-05	0.000222	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GLUL—liver cancer	2.12e-05	0.000221	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CPT1B—liver cancer	2.12e-05	0.000221	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSMA4—liver cancer	2.12e-05	0.000221	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSMD10—liver cancer	2.12e-05	0.000221	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HRAS—liver cancer	2.1e-05	0.000219	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GOT2—liver cancer	2.06e-05	0.000215	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.05e-05	0.000214	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NR1H4—liver cancer	2.04e-05	0.000214	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.02e-05	0.000212	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	2.02e-05	0.000211	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—liver cancer	2.01e-05	0.00021	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTA3—liver cancer	2.01e-05	0.00021	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP2E1—liver cancer	1.94e-05	0.000202	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CG—liver cancer	1.93e-05	0.000202	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CPT1B—liver cancer	1.89e-05	0.000198	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GLUL—liver cancer	1.89e-05	0.000198	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UGDH—liver cancer	1.88e-05	0.000196	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.87e-05	0.000196	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.87e-05	0.000195	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPARG—liver cancer	1.86e-05	0.000195	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—AKT1—liver cancer	1.85e-05	0.000194	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTA4—liver cancer	1.84e-05	0.000192	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	1.82e-05	0.000191	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NR1H4—liver cancer	1.82e-05	0.000191	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYCS—liver cancer	1.81e-05	0.000189	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.79e-05	0.000188	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTA3—liver cancer	1.79e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTA2—liver cancer	1.79e-05	0.000187	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GGT1—liver cancer	1.78e-05	0.000186	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GOT1—liver cancer	1.78e-05	0.000186	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EPT1—liver cancer	1.76e-05	0.000184	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTA1—liver cancer	1.73e-05	0.000181	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GLUL—liver cancer	1.72e-05	0.00018	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CPT1B—liver cancer	1.72e-05	0.00018	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NAT2—liver cancer	1.71e-05	0.000178	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CD—liver cancer	1.7e-05	0.000177	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ALB—liver cancer	1.67e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TAT—liver cancer	1.67e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NR1H4—liver cancer	1.66e-05	0.000174	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.64e-05	0.000172	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTA4—liver cancer	1.64e-05	0.000171	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALDOB—liver cancer	1.64e-05	0.000171	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTA3—liver cancer	1.63e-05	0.000171	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.6e-05	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTA2—liver cancer	1.6e-05	0.000167	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTP1—liver cancer	1.6e-05	0.000167	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.59e-05	0.000167	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—HMOX1—liver cancer	1.57e-05	0.000165	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CRABP1—liver cancer	1.56e-05	0.000163	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTA1—liver cancer	1.54e-05	0.000161	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NAT2—liver cancer	1.52e-05	0.000159	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTA4—liver cancer	1.49e-05	0.000156	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CB—liver cancer	1.48e-05	0.000155	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CPT1B—liver cancer	1.47e-05	0.000154	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GLUL—liver cancer	1.47e-05	0.000154	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—liver cancer	1.47e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.46e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALDOB—liver cancer	1.46e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.46e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTA2—liver cancer	1.46e-05	0.000152	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NR1H4—liver cancer	1.42e-05	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.41e-05	0.000147	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTA1—liver cancer	1.4e-05	0.000147	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTA3—liver cancer	1.4e-05	0.000146	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CRABP1—liver cancer	1.39e-05	0.000146	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.39e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NAT2—liver cancer	1.39e-05	0.000145	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—liver cancer	1.37e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HPGDS—liver cancer	1.36e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.36e-05	0.000142	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.34e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALDOB—liver cancer	1.33e-05	0.000139	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—liver cancer	1.3e-05	0.000136	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTA4—liver cancer	1.28e-05	0.000134	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARA—liver cancer	1.27e-05	0.000133	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CRABP1—liver cancer	1.27e-05	0.000133	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.25e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.25e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTA2—liver cancer	1.24e-05	0.00013	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.24e-05	0.000129	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.22e-05	0.000128	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HPGDS—liver cancer	1.22e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSMD10—liver cancer	1.22e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSMA4—liver cancer	1.22e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.21e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTA1—liver cancer	1.2e-05	0.000126	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NAT2—liver cancer	1.19e-05	0.000124	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GOT2—liver cancer	1.18e-05	0.000124	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.14e-05	0.00012	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.14e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.14e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDOB—liver cancer	1.14e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GLUL—liver cancer	1.14e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CPT1B—liver cancer	1.14e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP2E1—liver cancer	1.11e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HPGDS—liver cancer	1.11e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.1e-05	0.000115	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.1e-05	0.000115	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NR1H4—liver cancer	1.1e-05	0.000115	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.09e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.09e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CRABP1—liver cancer	1.09e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSMD10—liver cancer	1.09e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSMA4—liver cancer	1.09e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA3—liver cancer	1.08e-05	0.000113	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.08e-05	0.000113	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GOT2—liver cancer	1.06e-05	0.00011	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—liver cancer	1.05e-05	0.00011	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYCS—liver cancer	1.04e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GOT1—liver cancer	1.02e-05	0.000107	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GGT1—liver cancer	1.02e-05	0.000107	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.01e-05	0.000105	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP2E1—liver cancer	9.93e-06	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.92e-06	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSMA4—liver cancer	9.9e-06	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSMD10—liver cancer	9.9e-06	0.000104	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA4—liver cancer	9.85e-06	0.000103	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.77e-06	0.000102	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GOT2—liver cancer	9.63e-06	0.000101	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.61e-06	0.000101	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA2—liver cancer	9.6e-06	0.0001	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CD—liver cancer	9.57e-06	0.0001	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HPGDS—liver cancer	9.49e-06	9.92e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—liver cancer	9.47e-06	9.91e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—liver cancer	9.45e-06	9.89e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.43e-06	9.87e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYCS—liver cancer	9.29e-06	9.71e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA1—liver cancer	9.26e-06	9.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—liver cancer	9.17e-06	9.59e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAT2—liver cancer	9.16e-06	9.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GGT1—liver cancer	9.11e-06	9.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GOT1—liver cancer	9.11e-06	9.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP2E1—liver cancer	9.05e-06	9.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMOX1—liver cancer	9.04e-06	9.46e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—liver cancer	9.01e-06	9.43e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDOB—liver cancer	8.78e-06	9.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.76e-06	9.17e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.59e-06	8.99e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.48e-06	8.87e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYCS—liver cancer	8.47e-06	8.86e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSMA4—liver cancer	8.46e-06	8.84e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSMD10—liver cancer	8.46e-06	8.84e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—liver cancer	8.43e-06	8.82e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CRABP1—liver cancer	8.38e-06	8.76e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CB—liver cancer	8.34e-06	8.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GGT1—liver cancer	8.31e-06	8.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GOT1—liver cancer	8.31e-06	8.69e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GOT2—liver cancer	8.23e-06	8.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—liver cancer	8.19e-06	8.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMOX1—liver cancer	8.07e-06	8.44e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A1—liver cancer	7.99e-06	8.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2E1—liver cancer	7.73e-06	8.09e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—liver cancer	7.52e-06	7.87e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.49e-06	7.83e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—liver cancer	7.46e-06	7.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—liver cancer	7.45e-06	7.79e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—liver cancer	7.36e-06	7.7e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMOX1—liver cancer	7.36e-06	7.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HPGDS—liver cancer	7.32e-06	7.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARA—liver cancer	7.31e-06	7.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYCS—liver cancer	7.24e-06	7.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A1—liver cancer	7.13e-06	7.46e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GOT1—liver cancer	7.1e-06	7.43e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GGT1—liver cancer	7.1e-06	7.43e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—liver cancer	6.86e-06	7.17e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—liver cancer	6.65e-06	6.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.56e-06	6.87e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSMA4—liver cancer	6.53e-06	6.83e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSMD10—liver cancer	6.53e-06	6.83e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARA—liver cancer	6.52e-06	6.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A1—liver cancer	6.5e-06	6.8e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—liver cancer	6.38e-06	6.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GOT2—liver cancer	6.35e-06	6.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMOX1—liver cancer	6.29e-06	6.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—liver cancer	6.26e-06	6.55e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—liver cancer	6.06e-06	6.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—liver cancer	6.04e-06	6.32e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2E1—liver cancer	5.97e-06	6.24e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARA—liver cancer	5.95e-06	6.22e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—liver cancer	5.86e-06	6.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.86e-06	6.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—liver cancer	5.59e-06	5.84e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYCS—liver cancer	5.58e-06	5.84e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1A1—liver cancer	5.56e-06	5.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CD—liver cancer	5.5e-06	5.75e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GGT1—liver cancer	5.48e-06	5.73e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GOT1—liver cancer	5.48e-06	5.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—liver cancer	5.43e-06	5.68e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—liver cancer	5.39e-06	5.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.34e-06	5.59e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—liver cancer	5.18e-06	5.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—liver cancer	5.09e-06	5.33e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—liver cancer	5.09e-06	5.32e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARA—liver cancer	5.08e-06	5.32e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—liver cancer	4.92e-06	5.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—liver cancer	4.92e-06	5.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CD—liver cancer	4.91e-06	5.14e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMOX1—liver cancer	4.85e-06	5.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—liver cancer	4.85e-06	5.07e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CB—liver cancer	4.79e-06	5.02e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.56e-06	4.77e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—liver cancer	4.52e-06	4.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CD—liver cancer	4.48e-06	4.68e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—liver cancer	4.42e-06	4.62e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—liver cancer	4.35e-06	4.55e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A1—liver cancer	4.29e-06	4.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CB—liver cancer	4.28e-06	4.48e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—liver cancer	4.2e-06	4.39e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—liver cancer	4.16e-06	4.35e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—liver cancer	4e-06	4.18e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARA—liver cancer	3.92e-06	4.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CB—liver cancer	3.9e-06	4.08e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CD—liver cancer	3.83e-06	4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—liver cancer	3.78e-06	3.95e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—liver cancer	3.36e-06	3.51e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CB—liver cancer	3.33e-06	3.49e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—liver cancer	3.24e-06	3.39e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CD—liver cancer	2.95e-06	3.09e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—liver cancer	2.92e-06	3.06e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—liver cancer	2.91e-06	3.05e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—liver cancer	2.61e-06	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CB—liver cancer	2.57e-06	2.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—liver cancer	2.39e-06	2.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—liver cancer	2.38e-06	2.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—liver cancer	2.13e-06	2.23e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—liver cancer	2.03e-06	2.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—liver cancer	1.94e-06	2.03e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—liver cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—liver cancer	1.57e-06	1.64e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—liver cancer	1.28e-06	1.34e-05	CbGpPWpGaD
